Evidence map›Paper›PMID 42008486›Full record

ArticlePLoS pathogens2026

Prion propagation is controlled by a hierarchical network involving the nuclear Tfap2c and hnRNP K factors and the cytosolic mTORC1 complex.

Stefano Sellitto, Davide Caredio, Matteo Bimbati, Giovanni Mariutti, Martina Cerisoli, Lukas Frick, Vangelis Bouris, Carlos Omar Oueslati Morales, Dalila Laura Vena, Sandesh Neupane and 6 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Stefano SellittoInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-2579-6271
Davide CaredioInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Matteo BimbatiInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Giovanni MariuttiInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Martina CerisoliInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Lukas FrickInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Vangelis BourisInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Carlos Omar Oueslati MoralesInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Dalila Laura VenaInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Sandesh NeupaneInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Federico BaroniInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Kathi GingInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Jiang-An YinInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Elena De CeccoInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Andrea ArmaniInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Adriano AguzziInstitute for the Science of the Aging Brain, St. Gallen, Switzerland.ORCID 0000-0002-0344-6708

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterogeneous Nuclear Ribonucleoprotein K (hnRNP K) is a limiting factor for prion propagation. However, little is known about the function of hnRNP K except that it is essential to cell survival. Here, we performed a synthetic-viability CRISPR ablation screen to identify epistatic interactors of HNRNPK. We found that deletion of Transcription Factor AP-2γ (TFAP2C) suppressed the death of hnRNP K-depleted LN-229 and U-251 MG cells, whereas its overexpression hypersensitized cells to hnRNP K loss. HNRNPK ablation decreased cellular ATP, downregulated genes related to lipid and glucose metabolism, and enhanced autophagy. Co-occurrent deletion of TFAP2C reversed these effects, restoring transcriptional balance and alleviating energy deficiency. We linked HNRNPK and TFAP2C functional and genetic interaction to mTOR signaling, observing that hnRNP K depletion inhibited mTORC1 activity through downregulation of mTOR and Rptor, while TFAP2C overexpression enhanced mTORC1 downstream functions. In prion-infected cells, TFAP2C activation reduced prion levels and countered the increased prion propagation caused by HNRNPK suppression. Short-term inhibition of mTORC1 also elevated prion levels and partially mimicked the effects of HNRNPK silencing. Our study identifies TFAP2C as a genetic interactor of HNRNPK, implicates their roles in mTOR metabolic regulation, and establishes a causative link between these activities and prion propagation.

Indexed as

Heterogeneous-Nuclear Ribonucleoprotein KMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPrionsTOR Serine-Threonine KinasesTranscription Factor AP-2CytosolHumansSignal TransductionHeterogeneous-Nuclear Ribonucleoprotein KMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPrionsTOR Serine-Threonine KinasesTranscription Factor AP-2

Identifiers

PMID42008486
PMCPMC13108870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.